HCPLive
MAY 9, 2024
In an interview with Adler at APA 2024, he also explained how adults with ADHD may present additional symptoms not noted on the DSM when they have comorbidities.
Becker's Hospital Review - Cardiology
MAY 9, 2024
The majority of adults 20 and older meet criteria for cardiovascular-kidney-metabolic syndrome, putting them at risk of developing full-blown heart disease, according to new research.
HCPLive
MAY 9, 2024
At ARVO 2024, Deepayan Kar, MD, PhD, describes the potential of measuring contrast sensitivity function using a novel gaze tracking-based VR headset in AMD.
Cardiovascular Diabetology
MAY 9, 2024
To investigate the contributions of low-grade inflammation measured by C-reactive protein (CRP), hyperglycaemia, and type 2 diabetes to risk of ischemic heart disease (IHD) and cardiovascular disease (CVD) dea.
HCPLive
MAY 9, 2024
In an interview with HCPLive, Barnett discussed the ethical concerns of using psychedelics for treating substance use disorders.
Cardiovascular Diabetology
MAY 9, 2024
Studies have shown that RASGRP1 was potently associated with the onset of type 2 diabetes mellitus (T2DM), and RASGRP1 rs7403531 was significantly correlated with islet function in T2DM patients. However, the eff.
HCPLive
MAY 9, 2024
Compass Pathways reports positive results for psilocybin in PTSD treatment, showing safety and symptom improvement in an open-label phase 2 study.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
HCPLive
MAY 9, 2024
These data highlight the safety, efficacy, and long-term disease control results of treatment with topical ruxolitinib for a subpopulation of adolescents with atopic dermatitis.
Journal of Cardiothoracic Surgery
MAY 9, 2024
Post liver transplantation (LT) patients endure high morbidity rate of multi-organ ischemic symptoms following reperfusion. We hypothesize that enhanced external counterpulsation (EECP) as a typical non-invasi.
HCPLive
MAY 9, 2024
Compass Pathways reports positive results for psilocybin in PTSD treatment, showing safety and symptom improvement in an open-label phase 2 study.
Frontiers in Cardiovascular Medicine
MAY 9, 2024
BackgroundRheumatic heart disease (RHD) is a preventable sequelae of group A beta hemolytic streptococcal infection leading to an immune reaction: acute rheumatic fever (ARF) and progressive heart valve dysfunction. RHD is the leading cause of acquired heart disease in children and young adults in Sudan and many low/middle-income countries. In 2018, the World Health Organization (WHO) issued a resolution for RHD mandating that each country adopt updated guidelines for ARF and RHD management.
HCPLive
MAY 9, 2024
This analysis was designed to look into the timing and specific elements which mediate the relationship between eczema and systemic antibiotic use.
DAIC
MAY 9, 2024
The American College of Cardiology (ACC) and the American Heart Association (AHA) today released a new clinical guideline for effectively managing individuals diagnosed with hypertrophic cardiomyopathy (HCM). Image courtesy: Getty Images christine.book Thu, 05/09/2024 - 15:33 May 9, 2024 — The American College of Cardiology ( ACC ) and the American Heart Association ( AHA ) today released a new clinical guideline for effectively managing individuals diagnosed with hypertrophic cardiomyopathy (HC
Open Heart
MAY 9, 2024
Objectives Myocardial revascularisation and cardiopulmonary bypass (CPB) can cause ischaemia-reperfusion injury, leading to myocardial and other end-organ damage. Volatile anaesthetics protect the myocardium in experimental studies. However, there is uncertainty about whether this translates into clinical benefits because of the coadministration of propofol and its detrimental effects, restricting myocardial protective processes.
HCPLive
MAY 9, 2024
Results suggest chronic hepatitis B virus is globally underassessed and undertreated, especially among women and Asian minorities in the West.
Open Heart
MAY 9, 2024
Background Atrial fibrillation (AF), a common, frequently asymptomatic cardiac arrhythmia, is a major risk factor for stroke. Identification of AF enables effective preventive treatment to be offered, potentially reducing stroke risk by up to two-thirds. There is international consensus that opportunistic AF screening is valuable though uncertainty remains about the optimum screening location and method.
HCPLive
MAY 9, 2024
At ARVO 2024, Roger Goldberg, MD explores the greater reductions in hard exudates achieved with faricimab than aflibercept in eyes with DME.
Becker's Hospital Review - Cardiology
MAY 9, 2024
A heart pump device the size of an AA battery could help children in need of a heart transplant wait at home rather than the hospital, Science Daily reported May 7.
HCPLive
MAY 9, 2024
These guidelines are designed to help clinicians incorporate the latest recommendations into their clinical practice.
HeartRhythm
MAY 9, 2024
Sudden arrhythmic death syndrome (SADS), characterized by an unknown or inconclusive cause of death at autopsy, together with a negative or non-lethal toxicology screening, is the most common cause of sudden cardiac death (SCD) in victims under the age of 35. The complete causality of SADS remains unclear, with drugs being a potential risk factor.
HCPLive
MAY 9, 2024
Sofosbuvir/velpatasvir/voxilaprevir rescue therapy was safe and effective, and SVR did not significantly differ based on genotype, cirrhosis, or first-line therapy.
American College of Cardiology
MAY 9, 2024
Is the long-term use of medications used for the treatment of attention-deficit/hyperactivity disorder (ADHD) associated with an increased risk for cardiovascular (CV) outcomes?
The American Journal of Cardiology
MAY 9, 2024
Publication date: Available online 8 May 2024 Source: The American Journal of Cardiology Author(s): Gianluca Di Pietro, Riccardo Improta, Ovidio De Filippo, Francesco Bruno, Lucia Ilaria Birtolo, Marco Tocci, Tommaso Fabris, Wael Saade, Riccardo Colantonio, Paola Celli, Gennaro Sardella, Giovanni Esposito, Giuseppe Tarantini, Mancone Massimo, Fabrizio D'Ascenzo
American College of Cardiology
MAY 9, 2024
JACC and The Lancet are bringing together their resources, expertise, and networks to disseminate high-quality research, foster interdisciplinary collaborations, and advance cardiovascular health worldwide.
NEJM Journal Watch - Cardiology
MAY 9, 2024
A randomized, controlled trial shows no benefit of LAA ligation.
Clinical Trial Results
MAY 9, 2024
Dr. C. Michael Gibson, Dr. Pam Taub, Dr.
Expert insights. Personalized for you.
118 
Let's personalize your content